Disease/Infection News

RSS

Study shows peripherally inserted central catheters have similar CLABSI risk in vulnerable patients

A new study reports that peripherally inserted central catheters (PICCs) do not reduce the risk of central line associated bloodstream infections (CLABSIs) in hospitalized patients. PICCs have become one of the most commonly used central venous catheters (CVCs) in healthcare settings since they are considered easier and safer to use, with less risk of CLABSIs.

7 Aug 2013

Researchers improve efficacy of RASV by modifying pathogen’s ability to survive in hostile environment

The bacterial pathogen Salmonella has a notorious capacity for infection. Last year alone, according to the Center for Disease Control, various species of Salmonella caused multistate disease outbreaks linked with contaminated peanut butter, mangoes, ground beef, cantaloupe, poultry, tuna fish, small turtles and dry dog food.

7 Aug 2013

Single antibiotic treatment safe and effective for children with invasive bloodstream infections

Children with invasive bloodstream infections treated with a single antibiotic are just as likely to overcome their infections as those who get two-drug therapy, but at half the risk of drug-induced kidney damage, according to results of a Johns Hopkins Children’s Center study.

6 Aug 2013

GSK gets green light from FDA to ship Fluarix Quadrivalent influenza vaccine to healthcare providers

GlaxoSmithKline announced today it has received U.S. Food and Drug Administration approval to start shipping 2013-2014 FLUARIX QUADRIVALENT (Influenza Virus Vaccine) to CDC distribution centers and U.S. healthcare providers. This is the first season that vaccines protecting against more than three strains of influenza (flu) will be commercially available.

6 Aug 2013

Universal HIV screening in emergency department superior to testing only those with apparent risk

Screening everyone for HIV in the emergency department may be superior to testing only those with apparent risk, when trying to identify patients with undiagnosed HIV infection, according to a new results by researchers at the University of Cincinnati.

6 Aug 2013

Celiac disease patients with persistent intestine damage are at higher risk of lymphoma

Patients with celiac disease who had persistent intestine damage (identified with repeat biopsy) had a higher risk of lymphoma than patients whose intestines healed, according to findings published in the August 6, 2013, issue of Annals of Internal Medicine.

6 Aug 2013

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

NanoViricides, Inc. said it has signed a non-disclosure agreement with the Lovelace Respiratory Research Institute. The Company intends to enter into a Master Services Agreement with LRRI for the IND-enabling efficacy studies of both its broad-spectrum injectable and oral FluCide drug candidates.

5 Aug 2013

Nano-machine cell killer offers new insight into fight against pathogens

This is a veritable mechanics of aggression on the nanoscale. Certain bacteria, including Staphylococcus aureus, have the ability to deploy tiny darts. This biological weapon kills the host cell by piercing the membrane.

5 Aug 2013

Decatur Memorial Hospital installs germ-zapping robots to kill bugs

As hospitals across the nation look for new and innovative ways to battle deadly pathogens and kill multi-drug resistant organisms that put patients at risk, Decatur Memorial Hospital (DMH) has taken a leap into the future with the installation of two germ-zapping robots that eliminate hard-to-kill bugs in hard-to-clean places.

3 Aug 2013

New study paves way for novel approaches to protect people from infections

A new study published by University of Utah researchers is paving the way for novel approaches related to how people are immunized to protect them from diseases.

3 Aug 2013

China CDC, Aeras sign MOU to advance research, development of new TB vaccines

With the global tuberculosis epidemic becoming more deadly, costly, and difficult to treat, Chinese Center for Disease Control and Prevention and Aeras today signed a memorandum of understanding to advance research and development of new tuberculosis vaccines. An improved TB vaccine offers the best hope for eliminating this airborne infectious disease that kills 1.4 million people worldwide each year.

3 Aug 2013

New findings may lead to first new animal model for hepatitis C virus

By differentiating monkey stem cells into liver cells and inducing successful infection, researchers from the Icahn School of Medicine at Mount Sinai have shown for the first time that the hepatitis C virus can replicate in monkeys, according to research published in the journal Gastroenterology.

3 Aug 2013

Combating antibiotic resistance: an interview with Ron Najafi, CEO NovaBay Pharmaceuticals

Approximately 80 years ago the first antibiotic was discovered by Sir Alexander Fleming, for which he was justifiably awarded the Nobel Prize in medicine.

2 Aug 2013

Physicians prescribe strongest antibiotics capable of killing multiple kinds of bacteria

When U.S. physicians prescribe antibiotics, more than 60 percent of the time they choose some of the strongest types of antibiotics, referred to as "broad spectrum," which are capable of killing multiple kinds of bacteria, University of Utah researchers show in a new study.

2 Aug 2013

FDA promise to "reboot" antibiotic development rules to combat rise in resistance falls short

The rise of antibiotic resistance among hospital-acquired infections is greater than the Centers for Disease Control and Prevention found in its 2008 analysis, according to an ahead-of-print article in the journal, Antimicrobial Agents and Chemotherapy.

2 Aug 2013

Microbiologists identify staph-killing compound that may be effective for osteomyelitis

Osteomyelitis, a debilitating bone infection most frequently caused by Staphylococcus aureus ("staph") bacteria, is particularly challenging to treat.

2 Aug 2013

Deletion of a protein improves ability to fight bacteria in mice with CGD

Deletion of a protein in white blood cells improves their ability to fight the bacteria staphylococcus aureus and possibly other infections in mice with chronic granulomatous disease (CGD), according to a National Institutes of Health study. CGD, a genetic disorder also found in people, is marked by recurrent, life-threatening infections. The study's findings appear online in The Journal of Clinical Investigation.

2 Aug 2013

LSUHSC dental school wins $1.8M grant to educate students about caring for HIV/AIDS patients

The LSU Health Sciences Center New Orleans School of Dentistry has been awarded a $1.8 million grant over five years by the Health Resources and Services Administration to support a "Community-Based Dental Partnership." Under the direction of Robert Barsley, DDS, JD, the program educates dental and dental hygiene students about caring for patients with HIV/AIDS, provides dental services to this patient population, and monitors quality of care.

2 Aug 2013

Breath analysis: Noninvasive way to quickly determine severity of bacterial infections

Breath analysis may prove to be an accurate, noninvasive way to quickly determine the severity of bacterial and other infections, according to a UC Irvine study appearing online today in the open-access journal PLOS ONE.

2 Aug 2013

MAPS method could speed development of new vaccines for serious pathogens

A new method of vaccine design, called the Multiple Antigen Presentation System, may result in vaccines that bring together the benefits of whole-cell and acellular or defined subunit vaccination.

1 Aug 2013

Disease/Infection News

Study shows peripherally inserted central catheters have similar CLABSI risk in vulnerable patients

Researchers improve efficacy of RASV by modifying pathogen’s ability to survive in hostile environment

Single antibiotic treatment safe and effective for children with invasive bloodstream infections

GSK gets green light from FDA to ship Fluarix Quadrivalent influenza vaccine to healthcare providers

Universal HIV screening in emergency department superior to testing only those with apparent risk

Celiac disease patients with persistent intestine damage are at higher risk of lymphoma

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

Nano-machine cell killer offers new insight into fight against pathogens

Decatur Memorial Hospital installs germ-zapping robots to kill bugs

New study paves way for novel approaches to protect people from infections

China CDC, Aeras sign MOU to advance research, development of new TB vaccines

New findings may lead to first new animal model for hepatitis C virus

Combating antibiotic resistance: an interview with Ron Najafi, CEO NovaBay Pharmaceuticals

Physicians prescribe strongest antibiotics capable of killing multiple kinds of bacteria

FDA promise to "reboot" antibiotic development rules to combat rise in resistance falls short

Microbiologists identify staph-killing compound that may be effective for osteomyelitis

Deletion of a protein improves ability to fight bacteria in mice with CGD

LSUHSC dental school wins $1.8M grant to educate students about caring for HIV/AIDS patients

Breath analysis: Noninvasive way to quickly determine severity of bacterial infections

MAPS method could speed development of new vaccines for serious pathogens

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News